CANCER IMMUNOTHERAPIES BY DESIGN

Serial Number 88918348
Registration 6215904
700

Registration Progress

Application Filed
May 15, 2020
Under Examination
Approved for Publication
Sep 22, 2020
Published for Opposition
Sep 22, 2020
Registered
Dec 8, 2020

Trademark Image

CANCER IMMUNOTHERAPIES BY DESIGN

Basic Information

Serial Number
88918348
Registration Number
6215904
Filing Date
May 15, 2020
Registration Date
December 8, 2020
Published for Opposition
September 22, 2020
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Dec 8, 2020
Registration
Registered
Classes
042 044

Rights Holder

ITEOS THERAPEUTICS, INC.

03
Address
139 Main Street
Cambridge, MA 02142

Ownership History

ITEOS THERAPEUTICS, INC.

Original Applicant
03
Cambridge, MA

ITEOS THERAPEUTICS, INC.

Owner at Publication
03
Cambridge, MA

ITEOS THERAPEUTICS, INC.

Original Registrant
03
Cambridge, MA

Legal Representation

Attorney
Frances M. Jagla

USPTO Deadlines

Next Deadline
392 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-12-08)
Due Date
December 08, 2026
Grace Period Ends
June 08, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

12 events
Date Code Type Description Documents
Dec 8, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Sep 22, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 22, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 2, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 20, 2020 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Aug 20, 2020 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Aug 20, 2020 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Aug 20, 2020 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 20, 2020 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Aug 13, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
May 29, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 19, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Scientific and medical research relating to oncological and autoimmune disorders
First Use Anywhere: Dec 19, 2011
First Use in Commerce: Jun 20, 2018
Class 044
Providing a website featuring information to patients and healthcare providers relating to oncological and autoimmune disorders
First Use Anywhere: Dec 19, 2011
First Use in Commerce: Jun 20, 2018

Classification

International Classes
042 044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"CANCER IMMUNOTHERAPIES"